Combination of variations in inflammation- and endoplasmic reticulum-associated genes as putative biomarker for bevacizumab response in KRAS wild-type colorectal cancer
Chemotherapy combined with the angiogenesis inhibitor bevacizumab (BVZ) is approved as a first-line treatment in metastatic colorectal cancer (mCRC). Limited clinical benefit underpins the need for improved understanding of resistance mechanisms and the elucidation of novel predictive biomarkers. We...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
June 17, 2020
|
| In: |
Scientific reports
Year: 2020, Jahrgang: 10 |
| ISSN: | 2045-2322 |
| DOI: | 10.1038/s41598-020-65869-2 |
| Online-Zugang: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1038/s41598-020-65869-2 Verlag, lizenzpflichtig, Volltext: https://www.nature.com/articles/s41598-020-65869-2 
|
| Verfasserangaben: | Ana Barat, Dominiek Smeets, Bruce Moran, Wu Zhang, Shu Cao, Sudipto Das, Rut Klinger, Johannes Betge, Verena Murphy, Orna Bacon, Elaine W. Kay, Nicole C.T. Van Grieken, Henk M. W. Verheul, Timo Gaiser, Nadine Schulte, Matthias P. Ebert, Bozena Fender, Bryan T. Hennessy, Deborah A. McNamara, Darran O’Connor, William M. Gallagher, Chiara Cremolini, Fotios Loupakis, Aparna Parikh, Christoph Mancao, Bauke Ylstra, Diether Lambrechts, Heinz-Josef Lenz, Annette T. Byrne & Jochen H.M. Prehn |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1727899202 | ||
| 003 | DE-627 | ||
| 005 | 20220818184606.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 200827s2020 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1038/s41598-020-65869-2 |2 doi | |
| 035 | |a (DE-627)1727899202 | ||
| 035 | |a (DE-599)KXP1727899202 | ||
| 035 | |a (OCoLC)1341357837 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Barat, Ana |e VerfasserIn |0 (DE-588)1216657114 |0 (DE-627)1727903870 |4 aut | |
| 245 | 1 | 0 | |a Combination of variations in inflammation- and endoplasmic reticulum-associated genes as putative biomarker for bevacizumab response in KRAS wild-type colorectal cancer |c Ana Barat, Dominiek Smeets, Bruce Moran, Wu Zhang, Shu Cao, Sudipto Das, Rut Klinger, Johannes Betge, Verena Murphy, Orna Bacon, Elaine W. Kay, Nicole C.T. Van Grieken, Henk M. W. Verheul, Timo Gaiser, Nadine Schulte, Matthias P. Ebert, Bozena Fender, Bryan T. Hennessy, Deborah A. McNamara, Darran O’Connor, William M. Gallagher, Chiara Cremolini, Fotios Loupakis, Aparna Parikh, Christoph Mancao, Bauke Ylstra, Diether Lambrechts, Heinz-Josef Lenz, Annette T. Byrne & Jochen H.M. Prehn |
| 264 | 1 | |c June 17, 2020 | |
| 300 | |a 12 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 27.08.2020 | ||
| 520 | |a Chemotherapy combined with the angiogenesis inhibitor bevacizumab (BVZ) is approved as a first-line treatment in metastatic colorectal cancer (mCRC). Limited clinical benefit underpins the need for improved understanding of resistance mechanisms and the elucidation of novel predictive biomarkers. We assessed germline single-nucleotide polymorphisms (SNPs) in 180 mCRC patients (Angiopredict [APD] cohort) treated with combined BVZ + chemotherapy and investigated previously reported predictive SNPs. We further employed a machine learning approach to identify novel associations. In the APD cohort IL8 rs4073 any A carriers, compared to TT carriers, were associated with worse progression-free survival (PFS) (HR = 1.51, 95% CI:1.03-2.22, p-value = 0.037) and TBK1 rs7486100 TT carriers, compared to any A carriers, were associated with worse PFS in KRAS wild-type (wt) patients (HR = 1.94, 95% CI:1.04-3.61, p-value = 0.037), replicating previous findings. Machine learning identified novel associations in genes encoding the inflammasome protein NLRP1 and the ER protein Sarcalumenin (SRL). A negative association between PFS and carriers of any A at NLRP1 rs12150220 and AA for SRL rs13334970 in APD KRAS wild-type patients (HR = 4.44, 95% CI:1.23-16.13, p-value = 0.005), which validated in two independent clinical cohorts involving BVZ, MAVERICC and TRIBE. Our findings highlight a key role for inflammation and ER signalling underpinning BVZ + chemotherapy responsiveness. | ||
| 700 | 1 | |a Smeets, Dominiek |e VerfasserIn |4 aut | |
| 700 | 1 | |a Moran, Bruce |e VerfasserIn |4 aut | |
| 700 | 1 | |a Zhang, Wu |e VerfasserIn |4 aut | |
| 700 | 1 | |a Cao, Shu |e VerfasserIn |4 aut | |
| 700 | 1 | |a Das, Sudipto |e VerfasserIn |4 aut | |
| 700 | 1 | |a Klinger, Rut |e VerfasserIn |4 aut | |
| 700 | 1 | |a Betge, Johannes |d 1986- |e VerfasserIn |0 (DE-588)108257421X |0 (DE-627)847674347 |0 (DE-576)455525021 |4 aut | |
| 700 | 1 | |a Murphy, Verena |e VerfasserIn |4 aut | |
| 700 | 1 | |a Bacon, Orna |e VerfasserIn |4 aut | |
| 700 | 1 | |a Kay, Elaine W. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Van Grieken, Nicole C. T. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Verheul, Henk M. W. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Gaiser, Timo |d 1975- |e VerfasserIn |0 (DE-588)1030402280 |0 (DE-627)735221685 |0 (DE-576)378226533 |4 aut | |
| 700 | 1 | |a Schulte, Nadine |d 1981- |e VerfasserIn |0 (DE-588)138942404 |0 (DE-627)703158511 |0 (DE-576)308939069 |4 aut | |
| 700 | 1 | |a Ebert, Matthias |d 1968- |e VerfasserIn |0 (DE-588)1030133522 |0 (DE-627)734827083 |0 (DE-576)377938432 |4 aut | |
| 700 | 1 | |a Fender, Bozena |e VerfasserIn |4 aut | |
| 700 | 1 | |a Hennessy, Bryan T. |e VerfasserIn |4 aut | |
| 700 | 1 | |a McNamara, Deborah A. |e VerfasserIn |4 aut | |
| 700 | 1 | |a O’Connor, Darran |e VerfasserIn |4 aut | |
| 700 | 1 | |a Gallagher, William M. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Cremolini, Chiara |e VerfasserIn |4 aut | |
| 700 | 1 | |a Loupakis, Fotios |e VerfasserIn |4 aut | |
| 700 | 1 | |a Parikh, Aparna |e VerfasserIn |4 aut | |
| 700 | 1 | |a Mancao, Christoph |e VerfasserIn |4 aut | |
| 700 | 1 | |a Ylstra, Bauke |e VerfasserIn |4 aut | |
| 700 | 1 | |a Lambrechts, Diether |e VerfasserIn |4 aut | |
| 700 | 1 | |a Lenz, Heinz-Josef |e VerfasserIn |4 aut | |
| 700 | 1 | |a Byrne, Annette T. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Prehn, Jochen H. M. |e VerfasserIn |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Scientific reports |d [London] : Springer Nature, 2011 |g 10(2020) Artikel-Nummer 9778, 12 Seiten |h Online-Ressource |w (DE-627)663366712 |w (DE-600)2615211-3 |w (DE-576)346641179 |x 2045-2322 |7 nnas |a Combination of variations in inflammation- and endoplasmic reticulum-associated genes as putative biomarker for bevacizumab response in KRAS wild-type colorectal cancer |
| 773 | 1 | 8 | |g volume:10 |g year:2020 |g extent:12 |a Combination of variations in inflammation- and endoplasmic reticulum-associated genes as putative biomarker for bevacizumab response in KRAS wild-type colorectal cancer |
| 856 | 4 | 0 | |u https://doi.org/10.1038/s41598-020-65869-2 |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 856 | 4 | 0 | |u https://www.nature.com/articles/s41598-020-65869-2 |x Verlag |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20200827 | ||
| 993 | |a Article | ||
| 994 | |a 2020 | ||
| 998 | |g 1030133522 |a Ebert, Matthias |m 1030133522:Ebert, Matthias |d 60000 |d 61100 |e 60000PE1030133522 |e 61100PE1030133522 |k 0/60000/ |k 1/60000/61100/ |p 16 | ||
| 998 | |g 138942404 |a Schulte, Nadine |m 138942404:Schulte, Nadine |d 60000 |d 61100 |e 60000PS138942404 |e 61100PS138942404 |k 0/60000/ |k 1/60000/61100/ |p 15 | ||
| 998 | |g 1030402280 |a Gaiser, Timo |m 1030402280:Gaiser, Timo |d 60000 |d 63400 |e 60000PG1030402280 |e 63400PG1030402280 |k 0/60000/ |k 1/60000/63400/ |p 14 | ||
| 998 | |g 108257421X |a Betge, Johannes |m 108257421X:Betge, Johannes |d 60000 |d 61100 |e 60000PB108257421X |e 61100PB108257421X |k 0/60000/ |k 1/60000/61100/ |p 8 | ||
| 999 | |a KXP-PPN1727899202 |e 3743140039 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"name":{"displayForm":["Ana Barat, Dominiek Smeets, Bruce Moran, Wu Zhang, Shu Cao, Sudipto Das, Rut Klinger, Johannes Betge, Verena Murphy, Orna Bacon, Elaine W. Kay, Nicole C.T. Van Grieken, Henk M. W. Verheul, Timo Gaiser, Nadine Schulte, Matthias P. Ebert, Bozena Fender, Bryan T. Hennessy, Deborah A. McNamara, Darran O’Connor, William M. Gallagher, Chiara Cremolini, Fotios Loupakis, Aparna Parikh, Christoph Mancao, Bauke Ylstra, Diether Lambrechts, Heinz-Josef Lenz, Annette T. Byrne & Jochen H.M. Prehn"]},"id":{"eki":["1727899202"],"doi":["10.1038/s41598-020-65869-2"]},"physDesc":[{"extent":"12 S."}],"recId":"1727899202","origin":[{"dateIssuedDisp":"June 17, 2020","dateIssuedKey":"2020"}],"relHost":[{"physDesc":[{"extent":"Online-Ressource"}],"recId":"663366712","disp":"Combination of variations in inflammation- and endoplasmic reticulum-associated genes as putative biomarker for bevacizumab response in KRAS wild-type colorectal cancerScientific reports","origin":[{"dateIssuedKey":"2011","publisherPlace":"[London] ; London","dateIssuedDisp":"2011-","publisher":"Springer Nature ; Nature Publishing Group"}],"pubHistory":["1, article number 1 (2011)-"],"language":["eng"],"type":{"media":"Online-Ressource","bibl":"periodical"},"note":["Gesehen am 12.07.24"],"id":{"issn":["2045-2322"],"eki":["663366712"],"zdb":["2615211-3"]},"part":{"year":"2020","volume":"10","text":"10(2020) Artikel-Nummer 9778, 12 Seiten","extent":"12"},"title":[{"title_sort":"Scientific reports","title":"Scientific reports"}]}],"person":[{"role":"aut","given":"Ana","family":"Barat","display":"Barat, Ana"},{"given":"Dominiek","role":"aut","family":"Smeets","display":"Smeets, Dominiek"},{"given":"Bruce","role":"aut","family":"Moran","display":"Moran, Bruce"},{"display":"Zhang, Wu","role":"aut","given":"Wu","family":"Zhang"},{"family":"Cao","given":"Shu","role":"aut","display":"Cao, Shu"},{"display":"Das, Sudipto","role":"aut","given":"Sudipto","family":"Das"},{"display":"Klinger, Rut","family":"Klinger","role":"aut","given":"Rut"},{"family":"Betge","role":"aut","given":"Johannes","display":"Betge, Johannes"},{"role":"aut","given":"Verena","family":"Murphy","display":"Murphy, Verena"},{"given":"Orna","role":"aut","family":"Bacon","display":"Bacon, Orna"},{"family":"Kay","given":"Elaine W.","role":"aut","display":"Kay, Elaine W."},{"family":"Van Grieken","role":"aut","given":"Nicole C. T.","display":"Van Grieken, Nicole C. T."},{"display":"Verheul, Henk M. W.","role":"aut","given":"Henk M. W.","family":"Verheul"},{"given":"Timo","role":"aut","family":"Gaiser","display":"Gaiser, Timo"},{"given":"Nadine","role":"aut","family":"Schulte","display":"Schulte, Nadine"},{"family":"Ebert","given":"Matthias","role":"aut","display":"Ebert, Matthias"},{"display":"Fender, Bozena","role":"aut","given":"Bozena","family":"Fender"},{"display":"Hennessy, Bryan T.","given":"Bryan T.","role":"aut","family":"Hennessy"},{"display":"McNamara, Deborah A.","family":"McNamara","role":"aut","given":"Deborah A."},{"family":"O’Connor","given":"Darran","role":"aut","display":"O’Connor, Darran"},{"role":"aut","given":"William M.","family":"Gallagher","display":"Gallagher, William M."},{"display":"Cremolini, Chiara","role":"aut","given":"Chiara","family":"Cremolini"},{"display":"Loupakis, Fotios","role":"aut","given":"Fotios","family":"Loupakis"},{"family":"Parikh","role":"aut","given":"Aparna","display":"Parikh, Aparna"},{"role":"aut","given":"Christoph","family":"Mancao","display":"Mancao, Christoph"},{"role":"aut","given":"Bauke","family":"Ylstra","display":"Ylstra, Bauke"},{"display":"Lambrechts, Diether","role":"aut","given":"Diether","family":"Lambrechts"},{"display":"Lenz, Heinz-Josef","given":"Heinz-Josef","role":"aut","family":"Lenz"},{"given":"Annette T.","role":"aut","family":"Byrne","display":"Byrne, Annette T."},{"given":"Jochen H. M.","role":"aut","family":"Prehn","display":"Prehn, Jochen H. M."}],"type":{"media":"Online-Ressource","bibl":"article-journal"},"language":["eng"],"note":["Gesehen am 27.08.2020"],"title":[{"title_sort":"Combination of variations in inflammation- and endoplasmic reticulum-associated genes as putative biomarker for bevacizumab response in KRAS wild-type colorectal cancer","title":"Combination of variations in inflammation- and endoplasmic reticulum-associated genes as putative biomarker for bevacizumab response in KRAS wild-type colorectal cancer"}]} | ||
| SRT | |a BARATANASMCOMBINATIO1720 | ||